Cytosorbents Corporation
CTSO
$0.78
$0.034.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.58M | -10.18M | -16.43M | -21.04M | -19.73M |
| Total Depreciation and Amortization | 1.67M | 1.70M | 1.71M | 1.74M | 2.11M |
| Total Amortization of Deferred Charges | 761.40K | 761.40K | 560.10K | 380.40K | 190.00K |
| Total Other Non-Cash Items | -358.50K | -2.71M | 4.46M | 9.14M | 1.71M |
| Change in Net Operating Assets | -1.38M | 654.20K | -3.37M | -4.65M | -2.77M |
| Cash from Operations | -9.89M | -9.78M | -13.06M | -14.43M | -18.49M |
| Capital Expenditure | -125.20K | -260.20K | -241.10K | -284.20K | -310.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -123.00K | -342.00K | -348.30K | -385.00K | -370.40K |
| Cash from Investing | -248.20K | -602.20K | -589.40K | -669.20K | -680.90K |
| Total Debt Issued | 0.00 | 0.00 | 15.00M | 15.00M | 15.00M |
| Total Debt Repaid | 0.00 | 0.00 | -4.38M | -5.00M | -5.00M |
| Issuance of Common Stock | 7.00M | 7.00M | 7.00M | 220.10K | 12.26M |
| Repurchase of Common Stock | -1.10K | -42.10K | -41.20K | -41.20K | -41.20K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -58.00K | -848.00K | -848.00K | -848.00K |
| Cash from Financing | 7.00M | 6.90M | 16.73M | 9.33M | 21.37M |
| Foreign Exchange rate Adjustments | 33.10K | 264.10K | -64.80K | -84.90K | -77.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.11M | -3.22M | 3.02M | -5.85M | 2.12M |